|
Feng Shao, Associate Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Non-Coding Rna | Chemotherapy Resistance | Pancreatic Cancer | Stellate Cells | Cancer Progression | Exosomes | Diagnosis | Targeted Therapy | Mechanism | Oncology |
|
Chunze Zhou, Associate Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Portal Hypertension | Interventional Treatment | Clinical Research | Cholangiocarcinoma | Nanomaterials | Liver Cancer | Immune Cells | Liver Diseases | Mechanism | Therapy |
|
Bairong Xia, Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Gynecological Oncology | Molecular Mechanisms | Targeted Therapy | Tumor Microenvironment | Treatment Resistance | Comprehensive Therapy | Immunotherapy | Cancer Research | Oncology | Clinical Studies |
|
Xingbing Wang, Chief Physician, Deputy Director of Hematology
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Immunotherapy | Hematological Tumors | Clinical Research | Translational Research | Chemotherapy | Molecular Therapy | Targeted Therapy | Cell Therapy | Oncology | Hematology |
|
Guodong Shen, Researcher
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Gastric Cancer | Geriatric Tumors | Targeted Therapy | Sarcopenia | Elderly | Prevention | Tumor-Induced | Skeletal Muscle | Reduction | Mechanism |
|
Yifu He, Professor, Chief Physician, Doctoral Supervisor
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Gastrointestinal Tumors | Diagnosis | Treatment | Molecular Targeting | Biological Therapy | Immunotherapy | Esophageal Cancer | Gastric Cancer | Liver Cancer | Pancreatic Cancer |
|
Dabing Huang, Associate Chief Physician
University of Science and Technology of China, Mayo Clinic College of Medicine
Area of Focus
Organoids | Organ-On-A-Chip | Tumor Microenvironment | Malignant Tumors | Pathogenesis | Treatment Resistance | Non-Coding Rna | Targeted Therapy | Immunotherapy | Clinical Applications |
